Orion OYJ (OTCMKTS:ORINY) Reaches New 12-Month High – Should You Buy?
by Mitch Edgeman · The Markets DailyOrion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) hit a new 52-week high during mid-day trading on Thursday. The stock traded as high as $48.7938 and last traded at $48.7938, with a volume of 124 shares trading hands. The stock had previously closed at $47.6750.
Orion OYJ Stock Performance
The company has a current ratio of 2.64, a quick ratio of 1.48 and a debt-to-equity ratio of 0.08. The stock’s 50-day moving average price is $45.03 and its 200-day moving average price is $40.92. The company has a market capitalization of $13.77 billion, a P/E ratio of 20.08 and a beta of 0.07.
Orion OYJ (OTCMKTS:ORINY – Get Free Report) last posted its earnings results on Friday, July 17th. The company reported $0.58 EPS for the quarter. Orion OYJ had a return on equity of 50.37% and a net margin of 28.52%.The company had revenue of $606.38 million during the quarter.
About Orion OYJ
Orion Oyj, also known as Orion Corporation, is a Finnish pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its activities include prescription medicines, self-care products and pharmaceutical active ingredients, with a focus on research-driven therapies as well as established and generic treatments.
The company’s human-health portfolio has included medicines for central nervous system disorders, respiratory diseases, oncology, pain management and other therapeutic areas.
Recommended Stories
- Five stocks we like better than Orion OYJ
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next